Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q2 2020 · 10-Q
Revenue—
Net Income-$7.12M-$7.12MN/M vs Q2 2019 EPS Diluted-$0.27-$0.27N/M vs Q2 2019 Operating Income-$7,125,831N/M Operating Cash Flowderived-$4,086,918N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 12, 2020 · 43 d after period end